2',2'-difluorodeoxycytidine 5'-triphosphate and Neoplasms

2',2'-difluorodeoxycytidine 5'-triphosphate has been researched along with Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ghazaly, E; Peters, GJ; Rizzuto, I	1
Airoldi, M; Cattel, L; Delprino, L; Milla, P; Passera, R; Pedani, F	1

Reviews

1 review(s) available for 2',2'-difluorodeoxycytidine 5'-triphosphate and Neoplasms

Article	Year
Pharmacological factors affecting accumulation of gemcitabine's active metabolite, gemcitabine triphosphate. Pharmacogenomics, 2017, Volume: 18, Issue:9 Topics: Antimetabolites, Antineoplastic; Biological Transport; Cytidine Triphosphate; Deoxycytidine; Gemcitabine; Humans; Neoplasms	2017

Trials

1 trial(s) available for 2',2'-difluorodeoxycytidine 5'-triphosphate and Neoplasms

Article	Year
Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 5 Topics: Adult; Aged; Cytidine Triphosphate; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Survival Analysis; Time Factors; Treatment Outcome	2006

Article

Year

Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 5

Topics: Adult; Aged; Cytidine Triphosphate; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Survival Analysis; Time Factors; Treatment Outcome

2006